Pheochromocytoma News and Research

RSS
Pheochromocytoma is a term used to refer to rare and mostly benign catecholamine-secreting tumors arising from the chromaffin cells found in the adrenal medulla or in the paraganglia (i.e. extra-adrenal pheochromocytoma). Clinical presentation can be highly variable and can mimic other diseases, but the condition typically presents with hypertension, palpitations, severe headaches, and sweating.
Novel radiotracer can identify nearly 30 types of malignant tumors

Novel radiotracer can identify nearly 30 types of malignant tumors

FDA approves first ever non-surgical treatment for rare neuroendocrine cancers

FDA approves first ever non-surgical treatment for rare neuroendocrine cancers

FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

YCC researchers suggest promising treatment for two rare inherited cancer syndromes

YCC researchers suggest promising treatment for two rare inherited cancer syndromes

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

Study identifies new mutations linked to hereditary neuroendocrine tumors

Study identifies new mutations linked to hereditary neuroendocrine tumors

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

New findings could pave way to develop drug therapies for necrosis-related diseases

New findings could pave way to develop drug therapies for necrosis-related diseases

Endocrine Society publishes Clinical Practice Guideline for treatment of rare adrenal tumors

Endocrine Society publishes Clinical Practice Guideline for treatment of rare adrenal tumors

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Novel SCLC tumour suppressor gene discovered

Novel SCLC tumour suppressor gene discovered

BD receives FDA approval for second prefilled injectable drug

BD receives FDA approval for second prefilled injectable drug

Researchers identify HIF2α gene mutation in cancer tumor cells

Researchers identify HIF2α gene mutation in cancer tumor cells

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

Shire announces update on approval status and availability of ProAmatine SOH drug

Shire announces update on approval status and availability of ProAmatine SOH drug

FP/TMEM127 gene germline mutations associated with adrenal gland tumors

FP/TMEM127 gene germline mutations associated with adrenal gland tumors

Grey's Anatomy features patient with von Hippel-Lindau disease

Grey's Anatomy features patient with von Hippel-Lindau disease

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

FDA updates Shire's ProAmatine medicine for symptomatic orthostatic hypotension treatment

FDA updates Shire's ProAmatine medicine for symptomatic orthostatic hypotension treatment